Trial Profile
A Double-Blind, Placebo-Controlled, Randomised Dose-Ranging Trial to Investigate the Efficacy of Avotermin (Juvista) in the Improvement of Scar Appearance When Applied to Approximated Wound Margins in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 May 2014
Price :
$35
*
At a glance
- Drugs Avotermin (Primary)
- Indications Scars
- Focus Therapeutic Use
- Sponsors Renovo
- 21 May 2014 New trial record